Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis.

Marine DekervelNicolas HenryMassimo TorreggianiLise-Marie PouteauJean-Paul ImielaChloé MellazaAnne-Sophie GarnierAmaury DujardinMarine AsfarAlexandra DucancelleAxelle PaquinSophie BlanchiVirginie BessonGiorgina Barbara PiccoliJean François Augusto

Published in: Clinical kidney journal (2021)

In maintenance HD patients, humoral response against SARS-CoV-2 was boosted after a third dose of BNT162b2, allowing seroconversion in more than half of non-responders. These data may support an intensified vaccination protocol with a third dose of BNT162b2 in dialysis patients.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
sars cov
ejection fraction
newly diagnosed
immune response
randomized controlled trial
prognostic factors
machine learning
ultrasound guided
respiratory syndrome coronavirus